89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Operating Expenses | 115,824 | 75,909 | 122,005 | 151,938 | 53,436 |
| Operating Income | -115,824 | -75,909 | -122,005 | -151,938 | -53,436 |
| Interest Expense | 1,137 | 1,267 | 1,191 | 2,362 | 874 |
| Other Income | 6,210 | 6,038 | 5,099 | 5,431 | 6,473 |
| Pre-tax Income | -110,751 | -71,138 | -118,097 | -148,869 | -47,837 |
| Income Tax | 753 | 137 | 257 | 204 | 134 |
| Net Income Continuous | -111,504 | -71,275 | -118,354 | -149,073 | -47,971 |
| Net Income | $-111,504 | $-71,275 | $-118,354 | $-149,073 | $-47,971 |
| EPS Basic Total Ops | -0.71 | -0.49 | -1.10 | -1.39 | -0.48 |
| EPS Basic Continuous Ops | -0.71 | -0.49 | -1.09 | -1.39 | -0.48 |
| EPS Diluted Total Ops | -0.71 | -0.49 | -1.10 | -1.39 | -0.48 |
| EPS Diluted Continuous Ops | -0.71 | -0.49 | -1.09 | -1.39 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.49 | -1.02 | -1.39 | -0.48 |
| EBITDA(a) | $-119,722 | $-75,444 | $-123,755 | $-154,236 | $-58,662 |